Phase I trial of TG02 plus dose-dense or metronomic temozolomide for recurrent anaplastic astrocytoma and glioblastoma in adults.

被引：5
|
作者：
Wu, Jing
Yuan, Ying
Cordova, Christine
Aboud, Orwa
Penas-Prado, Marta
Theeler, Brett James
Bryla, Christine
Su, Yu-Ting
Grajkowska, Ewa
McCoy, Ann
Boris, Lisa
Siegel, Christine
Antony, Ramya
Garren, Nancy
Lawhon, Tracy
Armstrong, Terri
Gilbert, Mark R.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] NIH, Bldg 10, Bethesda, MD 20892 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA
[4] Walter Reed Natl Mil Med Ctr, Gaithersburg, MD USA
[5] NCI, Med Oncol Branch, NIH, Bethesda, MD 20892 USA
[6] NCI, Bethesda, MD 20892 USA
[7] Leidos Biomed Res Inc, Frederick, MD USA
[8] Adastra Pharmaceut Inc, San Diego, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.2031
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2031
引用
收藏
页数：2
相关论文
共 50 条
  • [1] PHASE I TRIAL OF TG02 PLUS DOSE-DENSE OR METRONOMIC TEMOZOLOMIDE FOR ADULTS WITH RECURRENT ANAPLASTIC ASTROCYTOMA AND GLIOBLASTOMA
    Wu, Jing
    Bryla, Christine
    Mccoy, Ann
    Lisa, Boris
    Garren, Nancy
    Siegel, Christine
    Grajkowska, Ewa
    Theeler, Brett
    Park, Deric M.
    Parrott, Tracy
    Armstrong, Terri S.
    Yuan, Ying
    Gilbert, Mark R.
    NEURO-ONCOLOGY, 2017, 19 : 15 - 15
  • [2] PHASE I TRIAL OF TG02 PLUS DOSE-DENSE OR METRONOMIC TEMOZOLOMIDE FOR RECURRENT HIGH-GRADE ASTROCYTOMA IN ADULTS
    Wu, Jing
    Bryla, Christine
    Su, Yu-Ting
    Grajkowska, Ewa
    McCoy, Ann
    Boris, Lisa
    Antony, Ramya
    Garren, Nancy
    Siegel, Christine
    Cordova, Christine
    Aboud, Orwa
    Vera, Elizabeth
    Lawhon, Tracy
    Penas-Prado, Marta
    Theeler, Brett
    Mendoza, Tito
    Armstrong, Terri
    Yuan, Ying
    Gilbert, Mark
    NEURO-ONCOLOGY, 2019, 21 : 27 - 28
  • [3] Phase I trial of dose-escalating metronomic temozolomide plus bevacizumab and bortezomib for patients with recurrent glioblastoma
    McCracken, D. Jay
    Celano, Emma C.
    Voloschin, Alfredo D.
    Read, William L.
    Olson, Jeffrey J.
    JOURNAL OF NEURO-ONCOLOGY, 2016, 130 (01) : 193 - 201
  • [4] Phase I trial of dose-escalating metronomic temozolomide plus bevacizumab and bortezomib for patients with recurrent glioblastoma
    D. Jay McCracken
    Emma C. Celano
    Alfredo D. Voloschin
    William L. Read
    Jeffrey J. Olson
    Journal of Neuro-Oncology, 2016, 130 : 193 - 201
  • [5] Randomized Phase II Trial of Chemoradiotherapy Followed by Either Dose-Dense or Metronomic Temozolomide for Newly Diagnosed Glioblastoma
    Clarke, Jennifer L.
    Iwamoto, Fabio M.
    Sul, Joohee
    Panageas, Katherine
    Lassman, Andrew B.
    DeAngelis, Lisa M.
    Hormigo, Adilia
    Nolan, Craig P.
    Gavrilovic, Igor
    Karimi, Sasan
    Abrey, Lauren E.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (23) : 3861 - 3867
  • [6] PHASE I TRIAL OF DNX-2401 ONCOLYTIC ADENOVIRUS COMBINED WITH A SHORT COURSE OF DOSE-DENSE TEMOZOLOMIDE FOR RECURRENT GLIOBLASTOMA
    Perez-Larraya, J. Gallego
    Garcia-Moure, M.
    Gonzalez-Huarriz, M.
    Zalacain, M.
    Marrodan, L.
    Puigdelloses, M.
    Labiano, S.
    de la Nava, D.
    Laspidea, V.
    Ausejo, I.
    Hervas, I.
    Esparragosa, I.
    Giraldez, M.
    Dominguez, P.
    Martinez-Simon, A.
    Idoate, M.
    Fueyo, J.
    Gomez-Manzano, C.
    Patino, A.
    Diez-Valle, R.
    Tejada, S.
    Alonso, M.
    NEURO-ONCOLOGY, 2023, 25 : 120 - 120
  • [7] A multicenter cohort study of dose-dense temozolomide (21 of 28 days) for the treatment of recurrent anaplastic astrocytoma or oligoastrocytoma
    Neyns, Bart
    Chaskis, Cristo
    Joosens, Eric
    Menten, Johan
    D'Hondt, Lionel
    Branle, Fabrice
    Sadones, Jan
    Michotte, Alex
    CANCER INVESTIGATION, 2008, 26 (03) : 269 - 277
  • [8] A phase II clinical trial evaluating the efficacy and safety of apatinib combined with dose-dense temozolomide in recurrent glioblastoma
    Wang, Y.
    Tao, R.
    ANNALS OF ONCOLOGY, 2019, 30
  • [9] Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
    Gilbert, Mark R.
    Wang, Meihua
    Aldape, Kenneth D.
    Stupp, Roger
    Hegi, Monika E.
    Jaeckle, Kurt A.
    Armstrong, Terri S.
    Wefel, Jeffrey S.
    Won, Minhee
    Blumenthal, Deborah T.
    Mahajan, Anita
    Schultz, Christopher J.
    Erridge, Sara
    Baumert, Brigitta
    Hopkins, Kristen I.
    Tzuk-Shina, Tzahala
    Brown, Paul D.
    Chakravarti, Arnab
    Curran, Walter J., Jr.
    Mehta, Minesh P.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (32) : 4085 - +
  • [10] A PHASE II STUDY OF LAPATINIB AND DOSE-DENSE TEMOZOLOMIDE (TMZ) FOR ADULTS WITH RECURRENT EPENDYMOMA: A CERN CLINICAL TRIAL
    Gilbert, Mark
    Yuan, Ying
    Wani, Khalida
    Wu, Jimin
    Omuro, Antonio
    Lieberman, Frank
    Robins, H. Ian
    Gerstner, Elizabeth
    Wu, Jing
    Wen, Patrick
    Mikkelsen, Tom
    Armstrong, Terri
    Aldape, Ken
    NEURO-ONCOLOGY, 2014, 16
12345